Latest filing published 12 Mar 2026 for Ironwood Pharmaceuticals INC.
Gregory S. Martini discloses dealings in Ironwood Pharmaceuticals Inc to SEC (Form 4). In total, 6 filings cover trades dated from 27 January 2025 to 10 March 2026.
On the market, this insider has only sold: 4 sales, €91k in total. Outside the open market, there are 2 share grants. 2026 to date brings no purchases and 2 sales.
Most recently, on 12 March 2026, the filings show a share grant in Ironwood Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations